Kyverna Therapeutics
$8.25
32
-$0.10-1.2% Friday 20:00
-$0.01-0.12%Friday 23:30After hours
Statistics
Day High
8.26
Day Low
8.24
52W High
13.67
52W Low
3.6
Volume
9,764
Avg. Volume
-
Mkt Cap
510.21M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
18NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.13
-0.96
-0.8
-0.63
Expected EPS
-0.691266
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-161.31MNet Income
Analyst Ratings
27.00Average Price Target
The highest estimate is 29.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow KYTX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Allogene Therapeutics
ALLO
Mkt Cap697.89M
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
Fate Therapeutics
FATE
Mkt Cap291.16M
Gilead Sciences
GILD
Mkt Cap180.64B
Novartis
NVS
Mkt Cap292.35B
Pfizer
PFE
Mkt Cap159.36B
About
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
Show more...
CEO
Warner Biddle
Employees
149
Country
United States
ISIN
US5019761049
Listings
0 Comments
Share your thoughts
FAQ
What is Kyverna Therapeutics stock price today?▼
The current price of KYTX is $8.25 USD — it has decreased by -1.2% in the past 24 hours. Watch Kyverna Therapeutics stock price performance more closely on the chart.
What is Kyverna Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Kyverna Therapeutics stocks are traded under the ticker KYTX.
Is Kyverna Therapeutics stock price growing?▼
KYTX stock has fallen by -1.43% compared to the previous week, the month change is a +7.98% rise, over the last year Kyverna Therapeutics has showed a +109.39% increase.
What is Kyverna Therapeutics market cap?▼
Today Kyverna Therapeutics has the market capitalization of 510.21M
When is the next Kyverna Therapeutics earnings date?▼
Kyverna Therapeutics is going to release the next earnings report on November 18, 2026.
What were Kyverna Therapeutics earnings last quarter?▼
KYTX earnings for the last quarter are -0.63 USD per share, whereas the estimation was -0.68 USD resulting in a +7.13% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Kyverna Therapeutics revenue for the last year?▼
Kyverna Therapeutics revenue for the last year amounts to 0 USD.
What is Kyverna Therapeutics net income for the last year?▼
KYTX net income for the last year is -161.31M USD.
How many employees does Kyverna Therapeutics have?▼
As of September 05, 2026, the company has 149 employees.
In which sector is Kyverna Therapeutics located?▼
Kyverna Therapeutics operates in the Health & Wellness sector.
When did Kyverna Therapeutics complete a stock split?▼
Kyverna Therapeutics has not had any recent stock splits.
Where is Kyverna Therapeutics headquartered?▼
Kyverna Therapeutics is headquartered in EMERYVILLE, United States.